Relación entre las formas de reconocimiento y la congruencia de valores

2.5 AIMS

THE AIMS OF THIS STUDY WERE THREEFOLD:

1. To characterise the nature of the in vivo hepatic ^^P MRS abnormalities in chronic liver disease using in vitro MRS techniques.

(The results o f this study are detailed in chapter 3).

2. To correlate in vivo hepatic ^^P MRS changes in patients with chronic liver disease with in vitro MRS of liver extracts taken at the time of orthotopic liver transplantation.

(The results o f this study are detailed in chapter 4).

3. To investigate the changes in ^^P MR spectra in patients postoperatively with good allograft function and with chronic ductopenic rejection.

2.6 References

Aebli, W., and Reichen, J. (1991). The prognostic value of the serial determination of galactose elimination capacity in chronic active hepatitis. Schweizerische Med. Wochensch.

121: 970-976.

Aisen, AT, and Chenevert, T.L. (1989). MR spectroscopy: Clinical perspective. Radiology

173:593-599.

Angus, P.W, Dixon, RM., Rajagopalan, B., Ryley, N.G., Simpson, K.J., Peters, T.J., Jewell, D.P., and Radda G.K. (1990). A study of patients with alcoholic liver disease by ^^P nuclear magnetic resonance spectroscopy. Clin. Sci. 78: 33-38.

Bottomley, P. A. (1989). Human in vivo NMR spectroscopy in biomedicine: clinical tool or research probe. Radiology 170: 1-15.

Child C.G.III, and Turcotte, J.G. (1964). Surgery and portal hypertension. In: Child C.G. m ed. The liver and portal hypertension. W.B. Saunders, Philadelphia, pp 50-68.

Cohen, R.D., Henderson, RM., Des, R.A, Monson, J.P., and Smith, J.A. (1982). Metabolic acidosis. In: Ciba Foundation Symposium 84, Pitman, London, p20.

Cox, I.J., Coutts, G.A., Gadian, D.G, Ghosh, P., Sargentoni, J., and Young, I.R. (1991). Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver. Magn. Reson. Med\l'.57>-6\.

Cox, I T, Menon, D.K., Sargentoni, J., Bryant, D.J., Collins, A.G., Coutts, G.A., Des, R.A., Bell, J.D., Benjamin, I S., GDbey, S., Hodgson, H.J.F., and Morgan, M.Y. (1992). Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. J. Hepatol. 14: 265-275.

Dagnelie, P C , Menon, D.K., Cox, I.J., Bell, J.D., Sargentoni, J., Urenjak, J., and lies, R.A. (1992). Effect of L-alanine infusion on ^^P magnetic resonance of the normal liver: towards

in vivo biochemical pathology. Clin. Science 83: 183-190.

Gupta, R.K., and Moore, R.D. (1980). P NMR studies of intracellular free magnesium in the intact frog skeletal muscle. J. Biol. Chem. 256: 3987-3993.

Homeida, M., Roberts, C.J.C., Halliwell, M., et.al. (1979). Antipyrine clearance per unit volume of the liver. An assessment of liver function in chronic liver disease. Gut 20:596- 601.

lies, R.A., Stevens, A.N., Griffiths, J R., and Morris, P.O. (1985). Phosphorylation status of liver by ^^P NMR spectroscopy and its implications for metabolic control. A comparison of ^^P NMR spectroscopy {in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi. Biochem. J. 229:141-151.

Jalan, R., and Hayes, P.C.(1995). Quantitative tests of liver function. Aliment. Pharmacol

Therapeut. 9:263-270.

Menon, D.K., Sargentoni, J., Taylor-Robinson, S.D., Bell, J.D., Cox I.J., Bryant, D.J., Coutts, G.A,, Rolles, K., Burroughs, A.K., and Morgan, M.Y. (1995). Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology. 21: 417-427.

Meyerhoff, D.J., Boska, M.D., Thomas, A.M., and Weiner, M.W. (1989). Alcoholic liver disease: quantitative image-guided P-31 spectroscopy. Radiology 1989; 173: 393-400.

Munakata, T., Griffiths, R.D., Martin, P.A., Jenkins, S.A., Sheilds, R , and Edwards, R.H.T. (1993). An in vivo ^^P MRS study of patients with liver cirrhosis: progress towards a non- invasive assessment of disease severity. NMR Biomed. 6:168-172.

Oberhaensli, R., Rajagopalan, B., Galloway, G.J., Taylor, D.J., Radda, G.K. (1990). Study of human liver disease with P-31 magnetic resonance spectroscopy. Gut 31: 463-467.

Oellerich, M., Burdelski, M., and Lautz, M. etal. (1991). Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. Ther. Drug. Monit. 12: 219-226.

Pugh, R.N.H., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C., and Williams, R. (1973). Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60: 646-649.

Renner, E , Weigholtz, H , Huguenin, P., Arnaud, M.J., and Preisig, R. (1984). Caffeine: A model compound for measuring liver function. Hepatology 4: 38-46.

Ruiz-Cabello, J., and Cohen, J. S.(1992). Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 5: 226-233.

Skak, C , and Keiding, S. (1987). Methodological problems in use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver 7:155-162.

Taylor, D.J., Bore, P.J., Styles, P., Gadian, D .G , and Radda, GK. (1983). Bioenergetics of intact human muscle: a^^P nuclear magnetic resonance study. Mol. Biol Med. 1: 77-94.

Villeneuve, J.P., Infante-Rivard, C., Ampelas, M., et.al. (1986). Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology6: 928-931.

Wiesner, R.H., Ludwig, J., Krom, R.A.F., Hay, I.E., and van Hoek, B. (1993). Hepatic allograft rejection: new developments in terminology, diagnosis, prevention and treatment.

Chapter 3

IN VITRO PHOSPHORUS-31 M R